On December 31, 2001 Univec, Inc., acquired Physician and

New Post Public Reply Private Reply Replies (2) Message Board
toodles Airedale #1428
342
On December 31, 2001 Univec, Inc., acquired Physician and Pharmaceutical
Services, Inc., (PPSI) a company engaged in group purchasing (GPO) and promoting
Pharmaceutical company prescription samples to physicians for their patients. PPSI
reduces the cost in the prescription-sampling channel by providing efficient
fulfillment and tracking of prescription usage. PPSI's national network of pharmacies
fills the sample prescription on a discounted fee and the Company's mail service
fulfillment complements additional needs. PPSI's approach conforms to regulations
requiring increased accountability and elimination of diversion of prescription
samples, consequently reducing the exposure of physicians and pharmaceutical companies
to potential liabilities and non-compliance penalties. PPSI’s group purchasing programs
provide for reduces prices on prescription drugs and other products through leveraged
purchasing and closed system market share. Univec also is a distributor of a highly
regulated pharmaceutical drug, methadone and other prescription drug products.

Univec during late 2004 established the company as a distributor of specialty and
highly regulated pharmaceutical products. The company intends to expand the product line
to take further advantage of its group purchasing and closed systems purchasing.

Univec extended its product line to include a highly regulated pharmaceutical (methadone)
and other pharmaceutical products. The company will continue to sell it products through
large United States based wholesalers as well as direct in large bulk to the larger
customers of the company. The company’s group purchase programs and closed market purchasing
positions the company’s product line well.

Marketing of Pharmaceutical Company Drug Samples to Physicians

PPSI patient StarterScript prescription drug program allows the physician to provide
to the patient a cost effective means to support medication management from
both a clinical and economic perspective. The patient sees if they may tolerate
the medication under both the physician and pharmacist oversight.

The PPSI online network provides better marketing and clinical integration
information than traditional systems, and enables pharmaceutical companies to
maintain market share when competing with generic drugs. The PPSI information
system includes detailed information such as the individual sales
representative, zip codes, DEA number, pharmacy and prescribing physician. The
PPSI system provides pharmaceutical companies with an easy, safe way to offer
free samples through physicians and increase their value to patients who benefit
through savings on prescriptions. In addition, the PPSI system provides
incentives for chain drug stores to stock the pharmaceutical products and for
pharmaceutical companies to keep their products on managed care formularies.
Pharmaceutical manufacturers spend over $16 billion a year for the marketing of
products. PPSI's strategy is to provide flexible sample programs supported by
technology to assist with distribution, dispensing, reporting, and clinical
integration that maximizes the intent of appropriate sample model for marketing.

4

Sales, Marketing and Distribution

Univec has entered into several agreements with large United States based
wholesalers for the support and expansion of distribution channels for
nationwide delivery of the Univec product line.

Univec also markets its StarterScript patient prescription sampling services to
pharmaceutical companies desiring to maintain or expand market position. The company
management believes that with the growth of third party payments of prescription drug
such as Medicare and managed care companies the direct to consumer programs will grow.
Univec also believes that with more branded pharmaceutical products coming off patent will
further enhance direct patient sampling or StarterScript programs as an offense to generic drug substitution.

Univec has registered trademarks UNIVEC(R), and Rx Ultra(R), Rx Plus, The
Univec Crest and the symbol representing no second use, (i.e., the number 2
crossed out inside of a circle), with the United States Patent and Trademark
Office.

IMO HRI is just letters used for PPSI so competition want know what's going on.

TOODLES

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Taiwan's Bubble Tea Maker Shines in Sustainability Focus

Updated Category News Views 56

A Bubble Tea Brand Making Sustainable Waves Not many would imagine a bubble tea company shaking up the sustainability scene, but Empire Eagle Food Co. has done just that. Right from a rice field in Chishang, Taitung, once as silent as a whisper, four remarkable species made a comeback, and so did hope. The crested serpent eagle and pangolin alongside other wildlife became...

Continue Reading
TIER IV and TUM Propel Driverless Buses in Munich

Updated Category News Views 51

Revolutionizing Munich's Public Transit Let's dive headlong into one of the most ambitious autonomous driving projects that's underway in Europe's tech heart—Munich. Pioneering organizations, TIER IV and the Technical University of Munich (TUM), are combining forces to bring autonomous city buses to the bustling streets of Munich, powered by Autoware, the leading...

Continue Reading
HSF Opens Scholar Program to All Ethnicities

Updated Category News Views 517

Redefining Eligibility for Inclusive Progress Picture this: the landscape of educational support shifting towards inclusivity. The Hispanic Scholarship Fund (HSF), long a champion for Hispanic educational advancement, is taking a bold step by opening its doors wider. From January 2027, the HSF Scholar Program will embrace students of all backgrounds, a massive leap away...

Continue Reading
Amdocs Faces Turbulence Amidst T-Mobile Legal Strife

Updated Category News Views 47

Stock Plunge Strikes Amdocs Shareholders Hard A buddy of mine used to say, "Stocks don't care about your feelings," and these days, Amdocs investors would likely agree. November 4, 2026, marked a bloodbath for Amdocs (NASDAQ:DOX) shareholders, as the stock nosedived sharply. We're talking a 30% haircut in a single trading session—ouch. Amdocs had just dropped its fiscal...

Continue Reading
Millrose Faces Class Action for Alleged Deception

Updated Category News Views 75

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Continue Reading
PMET Exec Shakeup as Shaakichiuwaanaan Nears Development

Updated Category News Views 178

Turning Wheels at PMET: Leadership Shuffle in Motion There's a changing of the guard over at PMET Resources as they brace for the next big steps with their Shaakichiuwaanaan Project. Ken Brinsden, their long-time President and CEO, has decided it's time to pass the baton down the line, transitioning to Executive Chair next year. This move is all about keeping a steady...

Continue Reading
Kia's Landmark Triple Win at 2026 Car Awards

Updated Category News Views 119

Kia Makes History Well, folks, Kia has pulled off what many might have thought impossible. They snagged not one, not two, but three of Germany's Golden Steering Wheel awards. That's a real hat trick and a first for any non-European auto brand. With competition hotter than a stolen Tesla, Kia's not just keeping pace but setting it. The Golden Steering Wheel is one of those...

Continue Reading
Anchorage Home Sellers: Pricing Strategy Insights Revealed

Updated Category News Views 47

Understanding Anchorage's Real Estate Climate In the bustling world of Anchorage real estate, it's not what you hear nationally that counts—it's about reading the nuances of your own backyard. That’s the principal mantra disseminated by Real Estate Expert Gary Cox, affectionately known as the 'King', in his latest discourse with HelloNation. A pertinent perspective...

Continue Reading
Fluence Energy Lawsuit: Investor Unrest Unleashed

Updated Category News Views 45

The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...

Continue Reading
Eli Lilly's Taltz and Zepbound Deliver Promising Results

Updated Category News Views 26

Game-Changing Results for Psoriatic Arthritis Surprising everyone this side of the stock ticker, Eli Lilly (NYSE: LLY) just announced their new data: pairing Taltz (ixekizumab) with Zepbound brought a clinical revolution for folks battling psoriatic arthritis and obesity. It's like finding gold under your mat—a combo punching PsA better than Taltz going solo. AT 52...

Continue Reading

Top 5 Most Recently Viewed Articles

QYOU Media’s Upcoming Shareholder Call and New Developments

Updated Category News Views 302

QYOU Media CEO Curt Marvis to Host Shareholder Call QYOU Media Inc. is gearing up for a significant shareholder call led by CEO and Co-Founder Curt Marvis. This event is poised to update shareholders on exciting corporate developments and recent news surrounding the company. The live call will take place, offering a valuable opportunity for stakeholders to engage with the...

Continue Reading
Spiber and Consinee: A New Era in Sustainable Textiles

Updated Category News Views 40

Spiber and Consinee Group Extend Their Strategic Partnership Spiber Inc. is deepening its strategic partnership with Consinee Group, a globally recognized leader in premium yarn development. The collaboration pairs Spiber’s Brewed Protein™ fiber with Consinee’s long-honed yarn expertise to bring next-generation materials to high-end textiles. Both companies are...

Continue Reading
ICON Plc's Stock Slides: Key Insights and Future Outlook

Updated Category News Views 140

ICON Plc Reaches 52-Week Low Amid Market Fluctuations In the current economic climate, ICON Plc (ICLR) has seen its stock price hit a troublesome 52-week low, closing at $219.87. As a key player in providing outsourced development services for the pharmaceutical, biotechnology, and medical device sectors, the decline in shares reflects a troubling trend in the healthcare...

Continue Reading
HCA Healthcare Targets $76 Billion in Revenue Growth Potential

Updated Category News Views 188

HCA Healthcare's Remarkable Second Quarter Performance HCA Healthcare Inc. (HCA), a prominent player in the hospital industry, recently disclosed impressive financial results for the second quarter of 2025, exceeding analysts' expectations in both revenue and earnings per share. This achievement demonstrates the company's resilience within the healthcare sector despite...

Continue Reading
Matic Partners with Floify to Enhance Digital Loan Experience

Updated Category News Views 188

Matic Partners with Floify to Enhance Digital Loan Experience Matic, a prominent player in the digital insurtech landscape, has recently announced an innovative partnership with Floify, a leading mortgage automation platform. This collaboration is poised to revolutionize the way home insurance is integrated into the mortgage process, allowing lenders and brokers to...

Continue Reading